Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Alzheimer's Disease

  Free Subscription

Articles published in BMC Neurol

Retrieve available abstracts of 43 articles:
HTML format

Single Articles

    July 2021
  1. WANG L, Li P, Hou M, Zhang X, et al
    Construction of a risk prediction model for Alzheimer's disease in the elderly population.
    BMC Neurol. 2021;21:271.
    PubMed     Abstract available

    May 2021
  2. STROEHLEIN JK, Vieluf S, Zimmer P, Schenk A, et al
    Learning to play golf for elderly people with subjective memory complaints: feasibility of a single-blinded randomized pilot trial.
    BMC Neurol. 2021;21:200.
    PubMed     Abstract available

    April 2021
  3. QIAN S, Chen K, Guan Q, Guo Q, et al
    Performance of Mattis dementia rating scale-Chinese version in patients with mild cognitive impairment and Alzheimer's disease.
    BMC Neurol. 2021;21:172.
    PubMed     Abstract available

    February 2021
  4. SHIMURA H, Saiko A, Hayashi A, Hattori N, et al
    Rivastigmine improves dual-task gait velocity in patients with Alzheimer's disease.
    BMC Neurol. 2021;21:61.
    PubMed     Abstract available

    November 2020
  5. OSAWA A, Maeshima S, Arai H, Kondo I, et al
    Dementia with aphasia and mirror phenomenon: examination of the mechanism using neuroimaging and neuropsychological findings: a case report.
    BMC Neurol. 2020;20:425.
    PubMed     Abstract available

  6. YU SY, Lian TH, Guo P, Li LX, et al
    Correlations of apathy with clinical symptoms of Alzheimer's disease and olfactory dysfunctions: a cross-sectional study.
    BMC Neurol. 2020;20:416.
    PubMed     Abstract available

    October 2020
  7. LEE P, Kim HR, Jeong Y
    Detection of gray matter microstructural changes in Alzheimer's disease continuum using fiber orientation.
    BMC Neurol. 2020;20:362.
    PubMed     Abstract available

    August 2020
  8. PEARSON A, Ajoy R, Crynen G, Reed JM, et al
    Molecular abnormalities in autopsied brain tissue from the inferior horn of the lateral ventricles of nonagenarians and Alzheimer disease patients.
    BMC Neurol. 2020;20:317.
    PubMed     Abstract available

    June 2020
  9. PARK KS, Ganesh AB, Berry NT, Mobley YP, et al
    The effect of physical activity on cognition relative to APOE genotype (PAAD-2): study protocol for a phase II randomized control trial.
    BMC Neurol. 2020;20:231.
    PubMed     Abstract available

    May 2020
  10. MIMURA Y, Kurose S, Takata T, Tabuchi H, et al
    Pisa syndrome induced by switching of a choline-esterase inhibitor treatment from donepezil to galantamine: a case report.
    BMC Neurol. 2020;20:183.
    PubMed     Abstract available

    April 2020
  11. TENG L, Li Y, Zhao Y, Hu T, et al
    Predicting MCI progression with FDG-PET and cognitive scores: a longitudinal study.
    BMC Neurol. 2020;20:148.
    PubMed     Abstract available

    March 2020
  12. KOUZUKI M, Ichikawa J, Shirasagi D, Katsube F, et al
    Detection and recognition thresholds for five basic tastes in patients with mild cognitive impairment and Alzheimer's disease dementia.
    BMC Neurol. 2020;20:110.
    PubMed     Abstract available

  13. ORTNER M, Drost R, Hedderich D, Goldhardt O, et al
    Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's disease.
    BMC Neurol. 2020;20:80.
    PubMed     Abstract available

    January 2020
  14. WATTMO C, Blennow K, Hansson O
    Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease.
    BMC Neurol. 2020;20:10.
    PubMed     Abstract available

    December 2019
  15. FEIS RA, Bouts MJRJ, Dopper EGP, Filippini N, et al
    Multimodal MRI of grey matter, white matter, and functional connectivity in cognitively healthy mutation carriers at risk for frontotemporal dementia and Alzheimer's disease.
    BMC Neurol. 2019;19:343.
    PubMed     Abstract available

    November 2019
  16. CHAI B, Gao F, Wu R, Dong T, et al
    Vitamin D deficiency as a risk factor for dementia and Alzheimer's disease: an updated meta-analysis.
    BMC Neurol. 2019;19:284.
    PubMed     Abstract available

  17. ZHANG YR, Ding YL, Chen KL, Liu Y, et al
    The items in the Chinese version of the Montreal cognitive assessment basic discriminate among different severities of Alzheimer's disease.
    BMC Neurol. 2019;19:269.
    PubMed     Abstract available

    October 2019
  18. ORTNER M, Drost R, Heddderich D, Goldhardt O, et al
    Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's disease.
    BMC Neurol. 2019;19:264.
    PubMed     Abstract available

    August 2019
  19. VAN GIAU V, Pyun JM, Suh J, Bagyinszky E, et al
    A pathogenic PSEN1 Trp165Cys mutation associated with early-onset Alzheimer's disease.
    BMC Neurol. 2019;19:188.
    PubMed     Abstract available

    July 2019
  20. WANG N, Chen J, Xiao H, Wu L, et al
    Application of artificial neural network model in diagnosis of Alzheimer's disease.
    BMC Neurol. 2019;19:154.
    PubMed     Abstract available

    May 2019
  21. CONNELLY PJ, Adams F, Tayar ZI, Khan F, et al
    Peripheral vascular responses to acetylcholine as a predictive tool for response to cholinesterase inhibitors in Alzheimer's disease.
    BMC Neurol. 2019;19:88.
    PubMed     Abstract available

    December 2018
  22. SANDELIUS A, Cullen NC, Kallen A, Rosengren L, et al
    Transient increase in CSF GAP-43 concentration after ischemic stroke.
    BMC Neurol. 2018;18:202.
    PubMed     Abstract available

    September 2018
  23. SABBAGH MN, Shi J, Lee M, Arnold L, et al
    Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer's disease dementia from normal controls: preliminary findings.
    BMC Neurol. 2018;18:155.
    PubMed     Abstract available

    July 2018
  24. LIN Y, Li B, Tang H, Xu Q, et al
    Shanghai cognitive intervention of mild cognitive impairment for delaying progress with longitudinal evaluation-a prospective, randomized controlled study (SIMPLE): rationale, design, and methodology.
    BMC Neurol. 2018;18:103.
    PubMed     Abstract available

    May 2018
  25. LI J, Wu L, Tang Y, Zhou A, et al
    Differentiation of neuropsychological features between posterior cortical atrophy and early onset Alzheimer's disease.
    BMC Neurol. 2018;18:65.
    PubMed     Abstract available

    April 2018
  26. MIYAKE K, Hara T, Oshima E, Kawada K, et al
    Creutzfeldt-Jakob disease with Alzheimer pathology, presenting with status epilepticus following repeated partial seizures: a case report and literature review.
    BMC Neurol. 2018;18:54.
    PubMed     Abstract available

    January 2018
  27. HUANG X, Liu H, Li X, Guan L, et al
    Revealing Alzheimer's disease genes spectrum in the whole-genome by machine learning.
    BMC Neurol. 2018;18:5.
    PubMed     Abstract available

  28. FENG L, Liao YT, He JC, Xie CL, et al
    Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease.
    BMC Neurol. 2018;18:4.
    PubMed     Abstract available

    October 2017
  29. LEE CC, Hsu SW, Huang CW, Chang WN, et al
    Effects of Homocysteine on white matter diffusion parameters in Alzheimer's disease.
    BMC Neurol. 2017;17:192.
    PubMed     Abstract available

  30. TU MC, Huang WH, Hsu YH, Lo CP, et al
    Correction to: Comparison of neuropsychiatric symptoms and diffusion tensor imaging correlates among patients with subcortical ischemic vascular disease and Alzheimer's disease.
    BMC Neurol. 2017;17:189.

    July 2017
  31. TU MC, Huang WH, Hsu YH, Lo CP, et al
    Comparison of neuropsychiatric symptoms and diffusion tensor imaging correlates among patients with subcortical ischemic vascular disease and Alzheimer's disease.
    BMC Neurol. 2017;17:144.
    PubMed     Abstract available

    May 2017
  32. WALLIN A, Kapaki E, Boban M, Engelborghs S, et al
    Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report.
    BMC Neurol. 2017;17:102.
    PubMed     Abstract available

  33. KANETA T, Katsuse O, Hirano T, Ogawa M, et al
    Voxel-wise correlations between cognition and cerebral blood flow using arterial spin-labeled perfusion MRI in patients with Alzheimer's disease: a cross-sectional study.
    BMC Neurol. 2017;17:91.
    PubMed     Abstract available

    April 2017
  34. LANE CA, Parker TD, Cash DM, Macpherson K, et al
    Study protocol: Insight 46 - a neuroscience sub-study of the MRC National Survey of Health and Development.
    BMC Neurol. 2017;17:75.
    PubMed     Abstract available

  35. ABUSHOUK AI, Elmaraezy A, Aglan A, Salama R, et al
    Bapineuzumab for mild to moderate Alzheimer's disease: a meta-analysis of randomized controlled trials.
    BMC Neurol. 2017;17:66.
    PubMed     Abstract available

    February 2017
  36. TAI SY, Chen CH, Chien CY, Yang YH, et al
    Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: a case control study.
    BMC Neurol. 2017;17:40.
    PubMed     Abstract available

    January 2017
  37. LI F, Chen S, Wei C, Jia J, et al
    Monetary costs of Alzheimer's disease in China: protocol for a cluster-randomised observational study.
    BMC Neurol. 2017;17:15.
    PubMed     Abstract available

    November 2016
  38. SHAFI O
    Inverse relationship between Alzheimer's disease and cancer, and other factors contributing to Alzheimer's disease: a systematic review.
    BMC Neurol. 2016;16:236.
    PubMed     Abstract available

  39. DEMING Y, Black K, Carrell D, Cai Y, et al
    Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40.
    BMC Neurol. 2016;16:217.
    PubMed     Abstract available

    August 2016
  40. SCHONECKER S, Brendel M, Huber M, Vollmar C, et al
    Applied multimodal diagnostics in a case of presenile dementia.
    BMC Neurol. 2016;16:131.
    PubMed     Abstract available

    June 2016
  41. BLANCO MARTIN E, Ugarriza Serrano I, Elcoroaristizabal Martin X, Galdos Alcelay L, et al
    Dysexecutive syndrome in amnesic mild cognitive impairment: a multicenter study.
    BMC Neurol. 2016;16:88.
    PubMed     Abstract available

    May 2016
  42. CHEN GQ, Sheng C, Li YX, Yu Y, et al
    Neuroimaging basis in the conversion of aMCI patients with APOE-epsilon4 to AD: study protocol of a prospective diagnostic trial.
    BMC Neurol. 2016;16:64.
    PubMed     Abstract available

    January 2016
  43. BERGE G, Sando SB, Albrektsen G, Lauridsen C, et al
    Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy controls: a two year follow-up study.
    BMC Neurol. 2016;16:180.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.